Filtered By:
Specialty: Neurology
Source: Neurology
Education: Study
This page shows you your search results in order of date. This is page number 12.
Order by Relevance | Date
Total 1979 results found since Jan 2013.
HELIAD study: Dementia prevalence in Greece (P3.095)
Conclusions:The prevalence of dementia and its subtypes in Greece is similar or at the lower range of that reported in many other European countries and globally. In our sample, increased age and decreased level of education status, but not gender, were predictive of a diagnosis of dementia with age being the strongest predictive factor.Study Supported by:Funding/Support: IIRG-09-133014 from the Alzheimer’s Association; 189 10276/8/9/2011 from the ESPA-EU program Excellence Grant (ARISTEIA) which is co-funded by the European Social Fund and Greek National resources; and Y2β/o.51657/14.4.2009 from the Ministry fo...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Sakka, P., Kosmidis, M., Yannakoulia, M., Dardiotis, E., Hadjigeorgiou, G., Scarmeas, N. Tags: Aging and Dementia: Epidemiologic Studies Source Type: research
Pulse Pressure in Ischemic Stroke Is an Independent Predictor for Long-Term Stroke Outcomes (P3.101)
Conclusions:Our study demonstrated the long-term prognostic implications of PP in ischemic stroke patients and the modification of this effect by age. In first-ever ischemic stroke patients ≥60 years of age, PP was an independent predictor for long-term stroke outcomes.Study Supported by: This study was funded by the National Key Technology Research and Development Program in the 12th 5-year plan of China.Disclosure: Dr. Su has nothing to disclose. Dr. Zhai has nothing to disclose. Dr. Ni has nothing to disclose. Dr. Zhou has nothing to disclose. Dr. Yao has nothing to disclose. Dr. Peng has nothing to disclose. Dr. Zhu...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Su, N., Zhai, F.-F., Ni, J., Zhou, L.-X., Yao, M., Peng, B., Zhu, Y.-C., Cui, L.-Y. Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research
Race and Sex Differences in tPA Utilization among Older Ischemic Stroke Patients (P3.102)
Conclusions:Among older Americans, women and blacks have lower odds of being treated with IV-tPA, even after adjusting for age, insurance and medical comorbidities. A greater understanding of the reasons for these unexplained differences in the fastest growing proportion of our population is needed.Disclosure: Dr. Lyerly has nothing to disclose. Dr. Vahidy has nothing to disclose. Dr. Donnelly has nothing to disclose. Dr. Booth has nothing to disclose. Dr. Albright has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Lyerly, M., Vahidy, F., Donnelly, J., Booth, K., Albright, K. Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research
IV tPA Utilization and Outcomes in Asian Americans (P3.103)
Conclusions:We confirmed U.S. ethnic differences in IV tPA utilization and found that Asians have lower rates of tPA treatment compared with Whites but higher rates than Blacks of Hispanics. Asians also have higher rates of hemorrhage and in-hospital death following tPA. These findings are limited by lack of data on stroke severity, mechanisms, and treatment times.Disclosure: Dr. Moya has nothing to disclose. Dr. Chong has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Moya, A., Chong, J. Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research
Clinical Simulation-based Usability Testing of a Mobile Telestroke System (P3.104)
Conclusions:Our study shows the feasibility and capability of a mobile telestroke system to accurately assess actors simulating stroke patients during transport.Study Supported by: Virginia Commonwealth University (VCU) Dean’s Enhancement Award, VCU CTSA (UL1TR000058) from the National Center for Advancing Sciences, CCTR Endowment Fund of Virginia Commonwealth University (VCU)Disclosure: Dr. Heath has nothing to disclose. Dr. Mehndiratta has nothing to disclose. Dr. Decker has nothing to disclose. Dr. Lawrence has nothing to disclose. Dr. Whitt has nothing to disclose. Dr. Fellows has nothing to disclose. Dr. Broadna...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Heath, K., Mehndiratta, P., Decker, C., Lawrence, R., Whitt, D., Fellows, D., Broadnax, T., Lavrentyev, V., Feldman, M., Henry, J., Wong, J., Ruiz, A., Hekmatodoost, K., Ono, K., Bhatti, M., Rahim, B., Toqeer, Q., Ricks, J., Madu, T., Blankson, B., Heath, Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research
Disability and mortality after permanent feeding tube placement in patients with acute stroke (P3.107)
Conclusions:In our large cohort of patients with acute stroke and PEG tubes, nearly 9/10 had severe disability at discharge. From discharge to 1 year, there was no difference in mortality between PEG and NG patient cohorts. These results suggest that PEG tubes serve mainly to prolong survival in patients discharged with severe disability. Our study may help support guideline creation and facilitate discussions with patients and families regarding PEG tube placement after acute stroke.Disclosure: Dr. Joundi has nothing to disclose. Dr. Saposnik has nothing to disclose. Dr. Martino has nothing to disclose. Dr. Fang has nothi...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Joundi, R., Saposnik, G., Martino, R., Fang, J., Giannakeas, V., Porter, J., Kapral, M. Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research
Stroke Call in the United States: Challenges and Opportunities in Vascular Neurology (P3.110A)
CONCLUSIONS:Correcting a perceived discontent about stroke call may improve fellowship recruitment, retention and the overall supply of Vascular Neurology specialists.Study Supported by: AAN Stroke and Vascular Neurology Section Stroke Practice Resources Workgroup: Edgar Kenton MD, Chair; Writing Group Antonio Culebras MD, Pierre Fayad MD, Larry Goldstein MD, Brian Kaskie MD, Helmi Lutsep MD, Larry Wechsler MD; for additional Workgroup, Jose Biller MD, Irene Katzan MD, James Stevens MD, David Wang MD, Nellie Adams.Disclosure: Dr. Kenton has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Kenton, E., Culebras, A., Fayad, P., Goldstein, L., Kaskie, B., Leira, E., Lutsep, H., Wechsler, L., Biller, J., Stevens, J., Wang, D., Adams, N. Tags: Cerebrovascular Disease and Interventional Neurology Poster Discussion Session Source Type: research
Correlation between MRI cerebral white matter changes, muscle structure and/or muscle function in myotonic dystrophy type 1 (DM1) (P3.113)
Conclusions:Correlations between global cerebral FA and muscle structure/function suggests a CNS role in DM1 neuromuscular dysfunction.Study Supported by: This study was supported by the National Institutes of Neurologic Disorders and Stroke (NINDS) grant 1R01NS094387, the National Center for Advancing Translational Sciences (NCATS) grant 1U54TR001356-01 The University of Iowa Clinical and Translational Science Award.Disclosure: Dr. Smith has nothing to disclose. Dr. Nopoulos has nothing to disclose. Dr. Shields has nothing to disclose. Dr. Thedens has nothing to disclose. Dr. Gutmann has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Smith, C., Nopoulos, P., Shields, R., Thedens, D., Gutmann, L. Tags: Myopathies & amp;amp; Myasthenia Gravis III Source Type: research
Edaravone (MCI-186) for the Treatment of Amyotrophic Lateral Sclerosis (ALS): A Posthoc Analysis of Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) by Domain and Individual Items (P3.130)
Conclusions:A generally favorable descriptive effect for edaravone was observed during posthoc assessment of the ALSFRS-R by domain and individual items.Study Supported by: MTPC was responsible for funding and conduct of the study. MTDA was responsible for executing this analysis.Disclosure: Dr. Palumbo has received personal compensation for activities with Mitsubishi Tanabe as an employee. Dr. Palumbo holds stock options in Actelion Clinical Research, Inc., in which his spouse is a full-time pharmaceutical researcher and receives stock options as partial compensation for work performed. Dr. Takei has received personal com...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Palumbo, J. M., Takei, K., Tsuda, K., Liu, S. Tags: Neuromuscular and Clinical Neurophysiology (EMG): Motor Neuron Disease I Source Type: research
A Common Data Language for Clinical Research Studies: The National Institute of Neurological Disorders and Stroke and National Library of Medicine Cerebral Aneurysms and Subarachnoid Hemorrhage Common Data Elements Version 1.0 Recommendations (P3.169)
Conclusions:NINDS encourages the use of CDEs by the clinical research community in order to standardize data collection across studies. The NINDS CDEs are a continually evolving resource, requiring updates as research advancements indicate. These newly developed SAH CDEs serve to be a valuable starting point for researchers and facilitate streamlining and sharing data. Information provided at this meeting will include examples of how the SAH CDEs and CRFs may be used by a research study, demonstrations of navigating the NINDS CDE and NIH CDE Repository websites and submitting feedback.Study Supported by: This project was f...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Sheikh, M., Alai, S., Esterlitz, J., Amos, L., Ludet, C., Odenkirchen, J., Suarez, J. Tags: Neurocritical Care: NICU Issues Source Type: research
"I believe in miracles": Implications for the Neuro-ICU (P3.181)
Conclusions:Preliminary data lack robustness to make definitive conclusions, however suggest possibility of shorter hospital LOS in those who don’t believe in miracles. Involvement of spiritual care early in the ICU may assist in important decision making with patients and family members.Disclosure: Dr. Ramineni has nothing to disclose. Dr. Dangayach has nothing to disclose. Dr. Griffiths has nothing to disclose. Dr. Keogh has nothing to disclose. Dr. Wheelwright has nothing to disclose. Dr. Sharma has nothing to disclose. Dr. Gidwani has nothing to disclose. Dr. Ahmad has nothing to disclose. Dr. Bederson has nothin...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Ramineni, A., Dangayach, N., Griffiths, S., Keogh, M., Wheelwright, D., Sharma, V., Gidwani, U., Ahmad, J., Bederson, J., Mocco, J., Mayer, S. Tags: Neurocritical Care: NICU Issues Source Type: research
Language competence and brain structural integrity in children with perinatal stroke (P3.205)
Conclusions:The right hemisphere (RH) may play a more prominent role in language development than commonly assumed. This is consistent with other studies indicating early RH involvement in language and at odds with the assumption that the left hemisphere is "hard-wired" to be dominant for language from birth. It may also be the case that complex interactions between hemispheres are required to facilitate language development.Study Supported by:Supported by NIH #P50 NS22343 (D Trauner, PI)Disclosure: Dr. Trauner has received research support from Novartis. Dr. Vu has nothing to disclose. Dr. Brown has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Trauner, D., Vu, L., Brown, T. Tags: Child Neurology I Source Type: research
Added value of interleukin-1 blockade to hypothermia in neonatal encephalopathy due to inflammatory-sensitized hypoxia-ischemia: a preclinical study. (P3.212)
Conclusions:Our results demonstrate that IL-1Ra (50mg/kg) has an added value to the neuroprotective effect of HT in LPS+HI-induced NE. This project could open new therapeutic avenues to prevent CP.Study Supported by:CIHR, FRQ-S, Heart and Stroke Foundation, "Tranzyme-Pharma" scholarship fom Université de Sherbrooke, and Foundation of Stars.Disclosure: Dr. Chevin has nothing to disclose. Dr. Guiraut has nothing to disclose. Dr. Sebire has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Chevin, M., Guiraut, C., Sebire, G. Tags: Child Neurology I Source Type: research
Recurrent transient hemiparesis and a novel ATP1A2 mutation (P3.220)
Conclusions:This case identifies a novel, potentially pathogenic mutation of the ATP1A2 gene corresponding to a phenotype of a rare migraine variant and contributes to our evolving understanding of migraine molecular genetics and pathophysiology.Study Supported by:Disclosure: Dr. Stredny has nothing to disclose. Dr. Winden has nothing to disclose. Dr. Danehy has nothing to disclose. Dr. Robertson has nothing to disclose. Dr. Trenor has nothing to disclose. Dr. Rivkin has nothing to disclose. Dr. Lehman has nothing to disclose. Dr. Bernson-Leung has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Stredny, C., Winden, K., Danehy, A., Robertson, R., Trenor, C., Rivkin, M., Lehman, L., Bernson-Leung, M. Tags: Child Neurology I Source Type: research
Does Body Mass Index Impact the Outcome of Stroke Patients Who Received Intravenous Thrombolysis (P3.080)
Conclusions:BMI was not associated with functional outcome and rate of sICH in AIS patients treated with IVT.Disclosure: Dr. Zambrano Espinoza has nothing to disclose. Dr. Vaughn has nothing to disclose. Dr. Crumlish has nothing to disclose. Dr. Deline has nothing to disclose. Dr. Ching has nothing to disclose. Dr. Sawyer has nothing to disclose. Dr. Mowla has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Espinoza, M. Z., Vaughn, C., Crumlish, A., Deline, C., Ching, M., Sawyer, R. N., Mowla, A. Tags: Cerebrovascular Disease and Interventional Neurology ePoster Session Source Type: research
